No takes yet. Share an insight, caveat, or question.
Structure-activity study demonstrates enhanced cardioselective anti-ischemic action in benzopyranyl cyanoguanidines in vitro, indicating separable cardiac and vascular channel targets.
Atwal et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: